메뉴 건너뛰기




Volumn 22, Issue 5, 2012, Pages 306-315

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; DYSTROPHIN; MORPHOLINO OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; VIVO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER;

EID: 84870344270     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0368     Document Type: Article
Times cited : (68)

References (54)
  • 1
    • 61649097962 scopus 로고    scopus 로고
    • Theoretic applicability of antisensemediated exon skipping for Duchenne muscular dystrophy mutations
    • AARTSMA-RUS, A., FOKKEMA, I., VERSCHUUREN, J., GINJAAR, I., et al. (2009). Theoretic applicability of antisensemediated exon skipping for Duchenne muscular dystrophy mutations. Hum. Mutat. 30, 293-299.
    • (2009) Hum. Mutat , vol.30 , pp. 293-299
    • Aartsma-Rus, A.1    Fokkema, I.2    Verschuuren, J.3    Ginjaar, I.4
  • 2
    • 33746928462 scopus 로고    scopus 로고
    • Exploring the Frontiers of Therapeutic Exon Skipping for Duchenne Muscular Dystrophy by Double Targeting within One or Multiple Exons
    • DOI 10.1016/j.ymthe.2006.02.022, PII S1525001606001298
    • AARTSMA-RUS, A., KAMAN, W.E., WEIJ, R., DEN DUNNEN, J.T., et al. (2006). Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons. Mol. Ther. 14, 401-407. (Pubitemid 44184959)
    • (2006) Molecular Therapy , vol.14 , Issue.3 , pp. 401-407
    • Aartsma-Rus, A.1    Kaman, W.E.2    Weij, R.3    Den Dunnen, J.T.4    Van Ommen, G.-Jan.B.5    Van Deutekom, J.C.T.6
  • 3
    • 34748906143 scopus 로고    scopus 로고
    • Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications
    • DOI 10.1261/rna.653607
    • AARTSMA-RUS, A., and VAN OMMEN, G.J. (2007). Antisensemediated exon skipping: A versatile tool with therapeutic and research applications. RNA 13, 1609-1624. (Pubitemid 47481669)
    • (2007) RNA , vol.13 , Issue.10 , pp. 1609-1624
    • Aartsma-Rus, A.1    Van Ommen, G.-J.B.2
  • 4
    • 32244443828 scopus 로고    scopus 로고
    • Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
    • DOI 10.1038/nm1345, PII NM1345
    • ALTER, J., LOU, F., RABINOWITZ, A., YIN, H., et al. (2006). Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat. Med. 12, 175-177. (Pubitemid 43214742)
    • (2006) Nature Medicine , vol.12 , Issue.2 , pp. 175-177
    • Alter, J.1    Lou, F.2    Rabinowitz, A.3    Yin, H.4    Rosenfeld, J.5    Wilton, S.D.6    Partridge, T.A.7    Qi, L.L.8
  • 6
    • 78049472917 scopus 로고    scopus 로고
    • In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse
    • AOKI, Y., NAKAMURA, A., YOKOTA, T., SAITO, T., et al. (2010). In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol. Ther. 18, 1995-2005.
    • (2010) Mol. Ther , vol.18 , pp. 1995-2005
    • Aoki, Y.1    Nakamura, A.2    Yokota, T.3    Saito, T.4
  • 8
    • 0042242582 scopus 로고    scopus 로고
    • ESEfinder: A web resource to identify exonic splicing enhancers
    • DOI 10.1093/nar/gkg616
    • CARTEGNI, L., WANG, J., ZHU, Z., ZHANG, M.Q., et al. (2003). ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568-3571. (Pubitemid 37442199)
    • (2003) Nucleic Acids Research , vol.31 , Issue.13 , pp. 3568-3571
    • Cartegni, L.1    Wang, J.2    Zhu, Z.3    Zhang, M.Q.4    Krainer, A.R.5
  • 9
    • 80051690306 scopus 로고    scopus 로고
    • Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study
    • CIRAK, S., ARECHAVALA-GOMEZA, V., GUGLIERI, M., FENG, L., et al. (2011). Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378, 595-605.
    • (2011) Lancet , vol.378 , pp. 595-605
    • Cirak, S.1    Arechavala-Gomeza, V.2    Guglieri, M.3    Feng, L.4
  • 10
    • 36048945922 scopus 로고    scopus 로고
    • ImageJ for microscopy
    • COLLINS, T.J. (2007). ImageJ for microscopy. Biotechniques 43, 25-30.
    • (2007) Biotechniques , vol.43 , pp. 25-30
    • Collins, T.J.1
  • 11
    • 78651068846 scopus 로고    scopus 로고
    • Diaphragm rescue alone prevents heart dysfunction in dystrophic mice
    • CRISP, A., YIN, H., GOYENVALLE, A., BETTS, C., et al. (2011). Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum. Mol. Genet. 20, 413-421.
    • (2011) Hum. Mol. Genet , vol.20 , pp. 413-421
    • Crisp, A.1    Yin, H.2    Goyenvalle, A.3    Betts, C.4
  • 12
    • 80052668013 scopus 로고
    • The pathology of paralysis with muscular degeneration (paralysie myosclerotique), or paralysis with apparent hypertrophy
    • DUCHENNE.
    • DUCHENNE. (1867). The pathology of paralysis with muscular degeneration (paralysie myosclerotique), or paralysis with apparent hypertrophy. Br. Med. J. 2, 541-542.
    • (1867) Br. Med. J , vol.2 , pp. 541-542
  • 13
    • 0031800293 scopus 로고    scopus 로고
    • Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides
    • DOI 10.1093/hmg/7.7.1083
    • DUNCKLEY, M.G., MANOHARAN, M., VILLIET, P., EPERON, I.C., et al. (1998). Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum. Mol. Genet. 7, 1083-1090. (Pubitemid 28306871)
    • (1998) Human Molecular Genetics , vol.7 , Issue.7 , pp. 1083-1090
    • Dunckley, M.G.1    Manoharan, M.2    Villiet, P.3    Eperon, I.C.4    Dickson, G.5
  • 14
    • 79955158683 scopus 로고    scopus 로고
    • Systemic administration of PRO051 in Duchenne's muscular dystrophy
    • GOEMANS, N.M., TULINIUS, M., VAN DEN AKKER, J.T., BURM, B.E., et al. (2011). Systemic administration of PRO051 in Duchenne's muscular dystrophy. N. Engl. J. Med. 364, 1513-1522.
    • (2011) N. Engl. J. Med , vol.364 , pp. 1513-1522
    • Goemans, N.M.1    Tulinius, M.2    Van Den Akker, J.T.3    Burm, B.E.4
  • 15
    • 74149093605 scopus 로고    scopus 로고
    • Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomermediated exon-skipping
    • GOYENVALLE, A., BABBS, A., POWELL, D., KOLE, R., et al. (2010). Prevention of dystrophic pathology in severely affected dystrophin/utrophin- deficient mice by morpholino-oligomermediated exon-skipping. Mol. Ther. 18, 198-205.
    • (2010) Mol. Ther , vol.18 , pp. 198-205
    • Goyenvalle, A.1    Babbs, A.2    Powell, D.3    Kole, R.4
  • 17
    • 80052513011 scopus 로고    scopus 로고
    • Restoring dystrophin expression in Duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through
    • HOFFMAN, E.P., BRONSON, A., LEVIN, A.A., TAKEDA, S., et al. (2011). Restoring dystrophin expression in Duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through. Am. J. Pathol. 179, 12-22.
    • (2011) Am. J. Pathol , vol.179 , pp. 12-22
    • Hoffman, E.P.1    Bronson, A.2    Levin, A.A.3    Takeda, S.4
  • 18
    • 0023614188 scopus 로고
    • Dystrophin: The protein product of the Duchenne muscular dystrophy locus
    • HOFFMAN, E.P., BROWN, R.H., JR., and KUNKEL, L.M. (1987). Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
    • (1987) Cell , vol.51 , pp. 919-928
    • Hoffman, E.P.1    Brown Jr., R.H.2    Kunkel, L.M.3
  • 19
    • 50549093417 scopus 로고    scopus 로고
    • Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
    • JEARAWIRIYAPAISARN, N., MOULTON, H.M., BUCKLEY, B., ROBERTS, J., et al. (2008). Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol. Ther. 16, 1624-1629.
    • (2008) Mol. Ther , vol.16 , pp. 1624-1629
    • Jearawiriyapaisarn, N.1    Moulton, H.M.2    Buckley, B.3    Roberts, J.4
  • 20
    • 74249109987 scopus 로고    scopus 로고
    • Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers
    • JEARAWIRIYAPAISARN, N., MOULTON, H.M., SAZANI, P., KOLE, R., et al. (2010). Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers. Cardiovasc. Res. 85, 444-453.
    • (2010) Cardiovasc. Res , vol.85 , pp. 444-453
    • Jearawiriyapaisarn, N.1    Moulton, H.M.2    Sazani, P.3    Kole, R.4
  • 21
    • 69949107887 scopus 로고    scopus 로고
    • Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: A single-blind, placebo-controlled, dose-escalation, proof-of-concept study
    • KINALI, M., ARECHAVALA-GOMEZA, V., FENG, L., CIRAK, S., et al. (2009). Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol. 8, 918-928.
    • (2009) Lancet Neurol , vol.8 , pp. 918-928
    • Kinali, M.1    Arechavala-Gomeza, V.2    Feng, L.3    Cirak, S.4
  • 22
    • 0023614271 scopus 로고
    • Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
    • DOI 10.1016/0092-8674(87)90504-6
    • KOENIG, M., HOFFMAN, E.P., BERTELSON, C.J., MONACO, A.P., et al. (1987). Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517. (Pubitemid 18098338)
    • (1987) Cell , vol.50 , Issue.3 , pp. 509-517
    • Koening, M.1    Hoffman, E.P.2    Bertelson, C.J.3    Monaco, A.P.4    Feener, C.5    Kunkel, L.M.6
  • 24
    • 78650916689 scopus 로고    scopus 로고
    • The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy
    • LU, Q.L., YOKOTA, T., TAKEDA, S., GARCIA, L., et al. (2011). The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy. Mol. Ther. 19, 9-15.
    • (2011) Mol. Ther , vol.19 , pp. 9-15
    • U, Q.L.L.1    Yokota, T.2    Takeda, S.3    Garcia, L.4
  • 25
    • 33745479703 scopus 로고    scopus 로고
    • Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
    • DOI 10.1038/sj.gt.3302800, PII 3302800
    • MCCLOREY, G., MOULTON, H.M., IVERSEN, P.L., FLETCHER, S., et al. (2006). Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther. 13, 1373-1381.1373-1381. (Pubitemid 44420632)
    • (2006) Gene Therapy , vol.13 , Issue.19 , pp. 1373-1381
    • McClorey, G.1    Moulton, H.M.2    Iversen, P.L.3    Fletcher, S.4    Wilton, S.D.5
  • 26
    • 58149339903 scopus 로고    scopus 로고
    • Vivo-Morpholinos: A non-peptide transporter delivers Morpholinos into a wide array of mouse tissues
    • 616, 618 passim
    • MORCOS, P.A., LI, Y., and JIANG, S. (2008). Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues. Biotechniques 45, 613-614, 616, 618 passim.
    • (2008) Biotechniques , vol.45 , pp. 613-614
    • Morcos, P.A.1    L, I.Y.2    Jiang, S.3
  • 27
    • 77958152873 scopus 로고    scopus 로고
    • Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
    • MOULTON, H.M., and MOULTON, J.D. (2010). Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy. Biochim. Biophys. Acta 1798, 2296-2303.
    • (2010) Biochim. Biophys. Acta , vol.1798 , pp. 2296-2303
    • Moulton, H.M.1    Moulton, J.D.2
  • 28
    • 70349453645 scopus 로고    scopus 로고
    • Peptide-morpholino conjugate: A promising therapeutic for Duchenne muscular dystrophy
    • MOULTON, H.M., WU, B., JEARAWIRIYAPAISARN, N., SAZANI, P., et al. (2009). Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy. Ann. N. Y. Acad. Sci. 1175, 55-60.
    • (2009) Ann. N. Y. Acad. Sci , vol.1175 , pp. 55-60
    • Moulton, H.M.1    W, U.B.2    Jearawiriyapaisarn, N.3    Sazani, P.4
  • 29
    • 63449133262 scopus 로고    scopus 로고
    • Gene knockdowns in adult animals: PPMOs and vivo-morpholinos
    • MOULTON, J.D., and JIANG, S. (2009). Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules 14, 1304-1323.
    • (2009) Molecules , vol.14 , pp. 1304-1323
    • Moulton, J.D.1    Jiang, S.2
  • 30
    • 44249125023 scopus 로고    scopus 로고
    • Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene
    • NAKAMURA, A., YOSHIDA, K., FUKUSHIMA, K., UEDA, H., et al. (2008). Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene. J. Clin. Neurosci. 15, 757-763.
    • (2008) J. Clin. Neurosci , vol.15 , pp. 757-763
    • Nakamura, A.1    Yoshida, K.2    Fukushima, K.3    Ueda, H.4
  • 31
    • 80052435477 scopus 로고    scopus 로고
    • Impending therapies for Duchenne muscular dystrophy
    • PARTRIDGE, T.A. (2011). Impending therapies for Duchenne muscular dystrophy. Curr. Opin. Neurol. 24, 415-422.
    • (2011) Curr. Opin. Neurol , vol.24 , pp. 415-422
    • Partridge, T.A.1
  • 32
    • 79955618736 scopus 로고    scopus 로고
    • Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
    • PICHAVANT, C., AARTSMA-RUS, A., CLEMENS, P.R., DAVIES, K.E., et al. (2011). Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol. Ther. 19, 830-840.
    • (2011) Mol. Ther , vol.19 , pp. 830-840
    • Pichavant, C.1    Aartsma-Rus, A.2    Clemens, P.R.3    Davies, K.E.4
  • 33
    • 0030582315 scopus 로고    scopus 로고
    • Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence
    • DOI 10.1006/bbrc.1996.1375
    • PRAMONO, Z.A., TAKESHIMA, Y., ALIMSARDJONO, H., ISHII, A., et al. (1996). Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence. Biochem. Biophys. Res. Commun. 226, 445-449. (Pubitemid 26331921)
    • (1996) Biochemical and Biophysical Research Communications , vol.226 , Issue.2 , pp. 445-449
    • Pramono, Z.A.D.1    Takeshima, Y.2    Alimsardjono, H.3    Ishii, A.4    Takeda, S.-I.5    Matsuo, M.6
  • 34
    • 0027976166 scopus 로고
    • An explanation for the constitutive exon 9 cassette splicing of the DMD gene
    • REISS, J., and RININSLAND, F. (1994). An explanation for the constitutive exon 9 cassette splicing of the DMD gene. Hum. Mol. Genet. 3, 295-298. (Pubitemid 24060945)
    • (1994) Human Molecular Genetics , vol.3 , Issue.2 , pp. 295-298
    • Reiss, J.1    Rininsland, F.2
  • 35
    • 77957913755 scopus 로고    scopus 로고
    • Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient
    • SAITO, T., NAKAMURA, A., AOKI, Y., YOKOTA, T., et al. (2010). Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient. PLoS One 5, e12239.
    • (2010) PLoS One , vol.5
    • Saito, T.1    Nakamura, A.2    Aoki, Y.3    Yokota, T.4
  • 36
    • 0026538578 scopus 로고
    • An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy
    • SHARP, N.J., KORNEGAY, J.N., VAN CAMP, S.D., HERBSTREITH, M.H., et al. (1992). An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13, 115-121.
    • (1992) Genomics , vol.13 , pp. 115-121
    • Sharp, N.J.1    Kornegay, J.N.2    Van Camp, S.D.3    Herbstreith, M.H.4
  • 38
    • 84863393197 scopus 로고    scopus 로고
    • A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy Dogs
    • SHIN, J.H., YUE, Y., SRIVASTAVA, A., SMITH, B., et al. (2012). A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy Dogs. Hum. Gene Ther. 23, 202-209.
    • (2012) Hum. Gene Ther , vol.23 , pp. 202-209
    • Shin, J.H.1    Yue, Y.2    Srivastava, A.3    Smith, B.4
  • 39
    • 80053898946 scopus 로고    scopus 로고
    • Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
    • TANIGUCHI-IKEDA, M., KOBAYASHI, K., KANAGAWA, M., YU, C.C., et al. (2011). Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478, 127-131.
    • (2011) Nature , vol.478 , pp. 127-131
    • Taniguchi-Ikeda, M.1    Kobayashi, K.2    Kanagawa, M.3    U, C.C.Y.4
  • 41
    • 34249276065 scopus 로고    scopus 로고
    • Sustained AAV-mediated dystrophin expression in a canine model of duchenne muscular dystrophy with a brief course of immunosuppression
    • DOI 10.1038/sj.mt.6300161, PII 6300161
    • WANG, Z., KUHR, C.S., ALLEN, J.M., BLANKINSHIP, M., et al. (2007). Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Mol. Ther. 15, 1160-1166. (Pubitemid 46813619)
    • (2007) Molecular Therapy , vol.15 , Issue.6 , pp. 1160-1166
    • Wang, Z.1    Kuhr, C.S.2    Allen, J.M.3    Blankinship, M.4    Gregorevic, P.5    Chamberlain, J.S.6    Tapscott, S.J.7    Storb, R.8
  • 42
    • 80052911776 scopus 로고    scopus 로고
    • An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice
    • WIDRICK, J.J., JIANG, S., CHOI, S.J., KNUTH, S.T., et al. (2011). An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice. Muscle Nerve 44, 563-570.
    • (2011) Muscle Nerve , vol.44 , pp. 563-570
    • Widrick, J.J.1    Jiang, S.2    Choi, S.J.3    Knuth, S.T.4
  • 43
    • 79956070948 scopus 로고    scopus 로고
    • Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development
    • WU, B., BENRASHID, E., LU, P., CLOER, C., et al. (2011a). Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development. PLoS One 6, e19906.
    • (2011) PLoS One , vol.6
    • W, U.B.1    Benrashid, E.2    L, U.P.3    Cloer, C.4
  • 44
    • 67349137953 scopus 로고    scopus 로고
    • Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice
    • WU, B., LI, Y., MORCOS, P.A., DORAN, T.J., et al. (2009). Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice. Mol. Ther. 17, 864-871.
    • (2009) Mol. Ther , vol.17 , pp. 864-871
    • W, U.B.1    L, I.Y.2    Morcos, P.A.3    Doran, T.J.4
  • 45
    • 74349109205 scopus 로고    scopus 로고
    • Dosedependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
    • WU, B., LU, P., BENRASHID, E., MALILK, S., et al. (2010). Dosedependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino. Gene Ther. 17, 132-140.
    • (2010) Gene Ther , vol.17 , pp. 132-140
    • W, U.B.1    L, U.P.2    Benrashid, E.3    Malilk, S.4
  • 46
    • 79952189079 scopus 로고    scopus 로고
    • Oneyear treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice
    • WU, B., XIAO, B., CLOER, C., SHABAN, M., et al. (2011b). Oneyear treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice. Mol. Ther. 19, 576-583.
    • (2011) Mol. Ther , vol.19 , pp. 576-583
    • W, U.B.1    Xiao, B.2    Cloer, C.3    Shaban, M.4
  • 47
    • 84865313416 scopus 로고    scopus 로고
    • Exon skipping for nonsense mutations in Duchenne muscular dystrophy: Too many mutations, too few patients?
    • YOKOTA, T., DUDDY, W., ECHIGOYA, Y., and KOLSKI, H. (2012). Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients? Expert Opin. Biol. Ther.
    • (2012) Expert Opin. Biol. Ther
    • Yokota, T.1    Duddy, W.2    Echigoya, Y.3    Kolski, H.4
  • 48
    • 43449113543 scopus 로고    scopus 로고
    • Optimizing exon skipping therapies for DMD
    • YOKOTA, T., DUDDY, W., and PARTRIDGE, T. (2007a). Optimizing exon skipping therapies for DMD. Acta Myol. 26, 179-184. Online document at: http://informahealthcare.com/doi/abs/10.1517/14712598.2012.693469 Accessed June 1, 2012. (Pubitemid 351668927)
    • (2007) Acta Myologica , vol.26 , Issue.3 , pp. 179-184
    • Yokota, T.1    Duddy, W.2    Partridge, T.3
  • 49
    • 79960055339 scopus 로고    scopus 로고
    • Antisense oligo-mediated multiple exon skipping in a dog model of Duchenne muscular dystrophy
    • YOKOTA, T., HOFFMAN, E.P., and TAKEDA, S. (2011). Antisense oligo-mediated multiple exon skipping in a dog model of Duchenne muscular dystrophy. Methods Mol. Biol. 709, 299-312.
    • (2011) Methods Mol. Biol , vol.709 , pp. 299-312
    • Yokota, T.1    Hoffman, E.P.2    Takeda, S.3
  • 50
    • 33746899641 scopus 로고    scopus 로고
    • Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration
    • DOI 10.1242/jcs.03000
    • YOKOTA, T., LU, Q.L., MORGAN, J.E., DAVIES, K.E., et al. (2006). Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J. Cell Sci. 119, 2679-2687. (Pubitemid 44184004)
    • (2006) Journal of Cell Science , vol.119 , Issue.13 , pp. 2679-2687
    • Yokota, T.1    Lu, Q.-L.2    Morgan, J.E.3    Davies, K.E.4    Fisher, R.5    Takeda, S.6    Partridge, T.A.7
  • 51
    • 63449141811 scopus 로고    scopus 로고
    • Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs
    • YOKOTA, T., LU, Q.L., PARTRIDGE, T., KOBAYASHI, M., et al. (2009a). Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann. Neurol. 65, 667-676.
    • (2009) Ann. Neurol , vol.65 , pp. 667-676
    • Yokota, T.1    U, Q.L.L.2    Partridge, T.3    Kobayashi, M.4
  • 52
    • 34250773365 scopus 로고    scopus 로고
    • Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy
    • DOI 10.1517/14712598.7.6.831
    • YOKOTA, T., PISTILLI, E., DUDDY, W., and NAGARAJU, K. (2007b). Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. Expert Opin. Biol. Ther. 7, 831-842. (Pubitemid 46954430)
    • (2007) Expert Opinion on Biological Therapy , vol.7 , Issue.6 , pp. 831-842
    • Yokota, T.1    Pistilli, E.2    Duddy, W.3    Nagaraju, K.4
  • 53
    • 58449122870 scopus 로고    scopus 로고
    • A renaissance for antisense oligonucleotide drugs in neurology: Exon skipping breaks new ground
    • YOKOTA, T., TAKEDA, S., LU, Q.L., PARTRIDGE, T.A., et al. (2009b). A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground. Arch. Neurol. 66, 32-38.
    • (2009) Arch. Neurol , vol.66 , pp. 32-38
    • Yokota, T.1    Takeda, S.2    U, Q.L.L.3    Partridge, T.A.4
  • 54
    • 0016769512 scopus 로고
    • Newborn screening for Duchenne muscular dystrophy
    • ZELLWEGER, H., and ANTONIK, A. (1975). Newborn screening for Duchenne muscular dystrophy. Pediatrics 55, 30-34.
    • (1975) Pediatrics , vol.55 , pp. 30-34
    • Zellweger, H.1    Antonik, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.